Showing results (551-560 of 1,019) with videos related to
Sort By:
Pageof 102
Journal of Pharmaceutical Policy and Practice|May 10, 2023
Antibiotic utilization pattern in treatment of acute diarrheal diseases: the case of Hiwot Fana Specialized University Hospital, Harar, EthiopiaBeyene Dereje, Shegaye Yibabie, Zenebe Keno, et al.Journal of Pharmaceutical Policy and Practice|May 2, 2023
Contracting retail pharmacies as a source of essential medicines for public sector clients in low- and middle-income countries: a scoping review of key considerations, challenges, and opportunitiesWarren A Kaplan, Carlotta M Cellini, Kwesi Eghan, et al.Journal of Pharmaceutical Policy and Practice|July 23, 2020
Unrealized potential of drug repositioning in europe during COVID-19 and beyond: a physcian's perspectiveA B Bayoumy, N K H de Boer, A R Ansari, et al.Journal of Pharmaceutical Policy and Practice|August 15, 2020
Registration and local production of essential medicines in UgandaPetra Brhlikova, Karen Maigetter, Jude Murison, et al.Journal of Pharmaceutical Policy and Practice|April 8, 2015
Economics and industry do not mean ethical conduct in clinical trialsJoel LexchinJournal of Pharmaceutical Policy and Practice|April 8, 2015
A research agenda to promote affordable and quality assured medicinesWarren A Kaplan, Veronika J WirtzJournal of Pharmaceutical Policy and Practice|April 8, 2015
Medicines discarded in household garbage: analysis of a pharmaceutical waste sample in ViennaSabine Vogler, Christine Leopold, Christel Zuidberg, et al.Journal of Pharmaceutical Policy and Practice|April 8, 2015
Physicians' perception of generic and electronic prescribing: A descriptive study from JordanFaris El-Dahiyat, Reem Kayyali, Penelope BidgoodJournal of Pharmaceutical Policy and Practice|April 27, 2021
Drug-related problems and associated factors in Ethiopia: a systematic review and meta-analysisFuad Adem, Jemal Abdela, Dumessa Edessa, et al.Journal of Pharmaceutical Policy and Practice|December 14, 2019
Imbalance in glycemic control between the treatment and placebo groups in cardiovascular outcome trials in type 2 diabetesRumiko Shimazawa, Masayuki IkedaPageof 102